Financial Data and Key Metrics Changes - Total Q2 revenues were $1,012,400,000, reflecting a 3.4% sequential increase but a 1.6% year-over-year decrease [6][16][24] - Clear aligner revenues for Q2 were $804,600,000, up 1% sequentially but down 3.3% year-over-year [16][17] - Overall gross margin for Q2 was 69.9%, up 0.5 points sequentially but down 0.3 points year-over-year [19][20] - Q2 operating income was $163,000,000, resulting in an operating margin of 16.1%, up 2.7 points sequentially and 1.7 points year-over-year [22][24] Business Line Data and Key Metrics Changes - Systems and services segment revenues for Q2 were $207,800,000, up 13.9% sequentially and 5.6% year-over-year, driven by higher scanner system revenue [9][18] - Clear aligner volumes increased slightly year-over-year in APAC and EMEA regions, but were offset by lower volumes in The Americas [10][12] - The average per case shipment price for clear aligners was $12.50, down $45 year-over-year due to discounts and a product mix shift [17][20] Market Data and Key Metrics Changes - In North America, clear aligner volumes were down slightly year-over-year, reflecting solid growth in the Latin America teen segment [11][12] - EMEA region saw year-over-year growth in clear aligner volume driven by increased utilization across both orthodontists and GP dentist channels [12] - APAC region experienced year-over-year growth in clear aligner volume, particularly in China [12][13] Company Strategy and Development Direction - The company plans to streamline operations and reallocate resources to align with long-term growth and profitability objectives, including reducing the global workforce and optimizing manufacturing [28][30] - The focus will be on innovation, efficiency, and execution, with investments in next-generation technology and treatment platforms [38][39] - The company aims to enhance customer engagement and improve case conversion through integrated consumer marketing programs [40][41] Management's Comments on Operating Environment and Future Outlook - Management noted that economic uncertainty, including US tariff turmoil and less affordable financing options, impacted demand for clear aligners and new iTero scanning systems [8][9] - Despite challenges, consumer interest in Invisalign treatment remains strong, and the company is focused on driving engagement and effectiveness of commercial marketing programs [9][38] - The outlook for Q3 anticipates continued economic uncertainty, with expected revenues in the range of $965,000,000 to $985,000,000 [33][34] Other Important Information - The company repurchased approximately 585,100 shares at an average price of $164.14 per share, completing a $1,000,000,000 stock repurchase program [26][27] - Cash and cash equivalents as of June 30, 2025, were $901,200,000, up $28,100,000 sequentially [25][27] Q&A Session Summary Question: Can you talk about case conversion trends across the quarter? - Management noted that case conversion was uneven, particularly in June, which did not materialize as expected, primarily affecting North America and parts of Europe [44][46] Question: What are the levers being pulled regarding orthodontists using more brackets and wires? - Management indicated that orthodontists who have not fully committed to digital solutions may revert to using wires and brackets due to economic pressures and inventory considerations [46][48] Question: How does the company view its market position relative to competitors? - Management stated that competitive dynamics have not changed significantly, and while there are pressures from competitors, the company remains confident in its market position [77][78] Question: Can you provide insights on the restructuring and its impact on manufacturing? - Management explained that the restructuring aims to optimize manufacturing and reduce costs, with a focus on transitioning to more efficient technologies [68][69]

Financial Data and Key Metrics Changes - Total Q2 revenues were $1,012,400,000, reflecting a 3.4% sequential increase but a 1.6% year-over-year decrease [5][14] - Clear aligner revenues for Q2 were $804,600,000, up 1% sequentially but down 3.3% year-over-year, primarily due to lower average selling prices (ASPs) and discounts [14][15] - Overall gross margin for Q2 was 69.9%, up 0.5 points sequentially but down 0.3 points year-over-year [18][19] - Net income per diluted share for Q2 was $1.72, up $0.45 sequentially and up $0.43 year-over-year [24] Business Line Data and Key Metrics Changes - Systems and services segment revenues for Q2 were $207,800,000, up 13.9% sequentially and 5.6% year-over-year, driven by higher scanner system revenue [8][17] - Clear aligner volumes increased slightly year-over-year in the APAC and EMEA regions, but were offset by lower volumes in The Americas [9][10] - The iTero Lumina scanner sales were strong, but full system sales were lower than expected, impacting overall revenue [5][14] Market Data and Key Metrics Changes - In North America, clear aligner volumes were down slightly year-over-year, while Latin America saw solid growth in the teen segment [10][11] - EMEA region clear aligner volume grew year-over-year, driven by increased utilization across both orthodontists and GP dentist channels [11] - APAC region clear aligner volume also grew year-over-year, led by increased submitters in China [11] Company Strategy and Development Direction - The company plans to streamline operations and reallocate resources to align with long-term growth and profitability objectives, including reducing workforce and optimizing manufacturing [28][29] - Focus on innovation and new product cycles to drive engagement and effectiveness in commercial marketing programs [7][38] - The company is committed to enhancing customer trust and providing value-based innovation to remain competitive [37][40] Management's Comments on Operating Environment and Future Outlook - Management noted that economic uncertainty, including US tariff turmoil and less affordable financing options, impacted demand for clear aligners and new iTero scanning systems [6][7] - Despite challenges, consumer interest in Invisalign treatment remains strong, and the company is focused on driving engagement and improving case conversion [36][39] - The outlook for Q3 anticipates continued economic uncertainty, with expected revenues in the range of $965,000,000 to $985,000,000 [32] Other Important Information - The company repurchased approximately 585,100 shares of common stock at an average price of $164.14 per share, completing a $1,000,000,000 stock repurchase program [26] - Clear aligner deferred revenues decreased year-over-year, indicating potential future revenue recognition challenges [17] Q&A Session Summary Question: Can you talk about case conversion trends across the quarter? - Management noted that case conversion was weaker than expected, particularly in June, which did not materialize as anticipated [44][45] Question: What levers can be pulled regarding the shift back to brackets and wires? - Management indicated that orthodontists not fully committed to digital solutions may revert to traditional methods due to economic pressures [46][47] Question: How does the company view its market share in the clear aligner market? - Management believes that competitive dynamics have not significantly changed, and they are not losing market share despite economic challenges [78] Question: What actions are being taken to stimulate demand? - The company is focusing on closer collaboration with doctors and enhancing marketing efforts to drive patient conversion [97]

Financial Data and Key Metrics Changes - Total revenues for Q1 2025 were $979.3 million, down 1.6% sequentially and down 1.8% year over year [18] - Q1 clear aligner revenues were $796.8 million, up 0.3% sequentially but down 2.5% year over year [18][20] - Q1 systems and services revenue was $182.4 million, down 9.2% sequentially but up 1.2% year over year [21] - Overall gross margin for Q1 was 69.5%, down 0.6 points sequentially and down 0.5 points year over year [22] - Q1 net income per diluted share was $1.27, down $0.13 sequentially and year over year [26][27] Business Line Data and Key Metrics Changes - Clear aligner volumes grew 6.2% year over year, with significant growth in the EMEA and APAC regions [6][7] - Systems and services revenues were slightly up year over year due to the adoption of the iTero Lumina scanner platform [6][21] - Q1 clear aligner average per case shipment price was $12.40, down $110 year over year due to product mix shifts and discounts [20] Market Data and Key Metrics Changes - North America saw a year-over-year increase in clear aligner volumes, driven by the adoption of Invisalign First and other products [7][9] - EMEA region volumes reflected strong demand across both orthodontic and GP channels [8] - APAC region growth was led by increased utilization in both ortho and GP channels across various markets [8] Company Strategy and Development Direction - The company is focused on innovation in orthodontics, including the launch of the Invisalign Pallet Expander and the iTero Lumina scanner with restorative capabilities [10][12] - Align Technology aims to enhance clinical outcomes and patient experiences through its digital platform and new product offerings [13][40] - The company is committed to expanding its market presence and improving operational efficiencies to drive growth [39][41] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of the clear aligner business despite global economic uncertainties [39] - The company anticipates Q2 2025 revenues to be in the range of $1.05 billion to $1.07 billion, indicating sequential growth [36] - Management highlighted the importance of digital workflows and the role of dental service organizations (DSOs) in driving growth [13][39] Other Important Information - The company received a favorable ruling regarding VAT applicability in the UK, which could enhance patient access to oral health [30] - Align Technology is actively managing tariff impacts through strategic production locations and supply chain adjustments [33][34] Q&A Session Summary Question: Strength in the quarter despite consumer sentiment decline - Management noted good volume growth across regions, particularly in North America, and highlighted the positive impact of new product launches [46][48] Question: Plans to mitigate tariff impacts - Management indicated confidence in their current production locations and supply chain strategies to mitigate tariff impacts [51][53] Question: Insights for the upcoming investor day - Management plans to provide a comprehensive overview of the company's technology and commercial positioning [55][56] Question: Clarification on 2025 revenue guidance and ASPs - Management confirmed that ASPs are expected to remain under pressure due to product mix shifts, but overall revenue growth is anticipated [58][60] Question: Performance of the teen segment - Management highlighted strong growth in the teen segment, driven by new products and effective distribution strategies [62][64] Question: ASP impacts from VAT and FX - Management discussed the potential for ASP improvements if the VAT situation in the UK is resolved favorably and noted that FX could become a positive contributor going forward [71][75]

Financial Data and Key Metrics Changes - Total revenues for Q1 2025 were $979.3 million, down 1.6% sequentially and down 1.8% year over year [18] - Q1 clear aligner revenues were $796.8 million, up 0.3% sequentially but down 2.5% year over year [19] - Q1 systems and services revenue was $182.4 million, down 9.2% sequentially but up 1.2% year over year [20] - Overall gross margin for Q1 was 69.5%, down 0.6 points sequentially and down 0.5 points year over year [22] - Q1 net income per diluted share was $1.27, down $0.13 sequentially and year over year [26] Business Line Data and Key Metrics Changes - Clear aligner volumes grew 6.2% year over year, with significant growth in the EMEA and APAC regions, and North America [6] - Systems and services revenues were slightly up year over year due to the adoption of the iTero Lumina scanner platform [7] - Clear aligner average per case shipment price decreased to $12.40, down $110 year over year due to product mix shifts and discounts [19] Market Data and Key Metrics Changes - North America saw a year-over-year increase in clear aligner volumes, driven by the adoption of Invisalign First for teens and kids [7] - EMEA region volumes reflected strong demand across both orthodontic and GP channels [8] - APAC region growth was driven by increased utilization in both ortho and GP channels across various markets [9] Company Strategy and Development Direction - The company is focused on innovation in orthodontics, including the launch of the Invisalign Pallet Expander system and the iTero Lumina scanner with restorative capabilities [10][11] - Align Technology aims to enhance clinical outcomes and patient experiences through its digital platform and new product offerings [12] - The company is committed to expanding its market presence and improving practice efficiency through digital workflows [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of the clear aligner business despite global economic uncertainties and potential headwinds from tariffs [40] - The company anticipates Q2 2025 revenues to be in the range of $1.05 billion to $1.07 billion, indicating sequential growth [36] - For fiscal 2025, Align expects clear aligner volume growth to be mid-single digits year over year, with systems and services revenues growing faster than clear aligner revenues [39] Other Important Information - The company received a favorable ruling regarding VAT applicability for clear aligner sales in the UK, which could enhance patient access to oral health [31] - Align Technology is actively managing its supply chain to mitigate potential tariff impacts, maintaining a strong global presence [34][35] Q&A Session Summary Question: Strength in the quarter despite consumer sentiment decline - Management noted good volume growth across regions, particularly in North America, APAC, and Europe, indicating a decoupling from consumer sentiment trends [46][48] Question: Plans to mitigate tariff impacts - Management stated they are well-positioned to handle tariff impacts through global supply lines and operational adjustments [50][52] Question: Insights for the upcoming investor day - Management indicated that the investor day will provide a comprehensive overview of the company's portfolio and future positioning [56] Question: Clarification on 2025 revenue guidance - Management confirmed that the revenue guidance reflects a slight adjustment in ASP expectations, with clear aligner volumes expected to grow mid-single digits [58][60] Question: ASP dynamics and impacts from VAT - Management explained that the VAT impact from the UK could provide flexibility in pricing, potentially benefiting ASPs if the appeal does not proceed [72][74]